| | | | | |
ANIK Anika Therapeutics Inc | €18,2242 | -1,34% | €252,48M | €68,68K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | €8,9579 | -0,19% | €252,41M | €1,21K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | €8,5983 | +0,00% | €252,37M | €4,30K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | €36,1572 | -2,18% | €252,23M | €23,60K | |
| €37,3733 | -3,34% | €252,08M | €16,26K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | €8,5554 | -0,10% | €252,08M | €6,01K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | €8,6325 | +0,00% | €252,07M | €142,59K | |
SLN Silence Therapeutics Plc American Depository Share | €11,6470 | -3,55% | €252,01M | €833,92K | |
MTNE CH4 Natural Solutions Corporation | €8,4698 | +0,19% | €251,68M | €2,91K | |
RXST RxSight, Inc. Common Stock | €5,2754 | -3,30% | €251,48M | €530,33K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | €9,1035 | -0,19% | €251,37M | €55,65K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | €8,5854 | +0,20% | €251,34M | €239,63K | |
CNXU Conexeu Sciences Inc. Common Stock | €7,6262 | -10,90% | €251,15M | €337,17K | |
| €8,8380 | +3,30% | €250,90M | €1,07M | |
JCE Nuveen Core Equity Alpha Fund | €14,5288 | -0,67% | €250,74M | €46,82K | |
